Cancer News and Research

Latest Cancer News and Research

Study shows targeted therapeutic after chemotherapy kills transitional cancer cells

Timing may be decisive when it comes to overcoming cancer's ability to evade treatment. By hitting breast cancer cells with a targeted therapeutic immediately after chemotherapy, researchers from Brigham and Women's Hospital (BWH) were able to target cancer cells during a transitional stage when they were most vulnerable, killing cells and shrinking tumors in the lab and in pre-clinical models.

12 Feb 2015

Common protein may play strategic role in tumor growth

A common, yet previously undistinguished protein, which is elevated in many late-stage cancers, may play a strategic role in tumor growth through a non-conventional pathway, researchers at the Indiana University School of Medicine report in the Feb. 10 issue of the Proceedings of the National Academy of Sciences.

12 Feb 2015

Opioid withdrawal in Ontario newborns increases 15-fold

The number of newborns suffering from opioid withdrawal increased 15-fold in Ontario over 20 years, according to research published today in CMAJ Open.

12 Feb 2015

Researchers develop novel approach to identify potential antimalarial drugs

Each year nearly 600,000 people--mostly children under age five and pregnant women in sub-Saharan Africa--die from malaria, caused by single-celled parasites that grow inside red blood cells. The most deadly malarial species--Plasmodium falciparum--has proven notoriously resistant to treatment efforts.

12 Feb 2015

Franziska Michor named winner of Creative Promise Prize in Biomedical Science

Franziska Michor was picked as the winner of a Creative Promise Prize in Biomedical Science for her research that fuses evolutionary biology, mathematics, and clinical research toward a better understanding of cancer genesis and treatments.

12 Feb 2015

Cervical treatment procedures do not affect fertility, shows study

Common surgical procedures used to diagnose and treat precancerous cervical lesions do not decrease women's chances of becoming pregnant, according to a study that followed nearly 100,000 women for up to 12 years.

12 Feb 2015

Sanford Health wins LocumTenens.com's Best Places to Practice Locum Tenens contest

Sanford Health, the nation's largest rural, not-for-profit healthcare system, has been named the winner of LocumTenens.com's Best Places to Practice Locum Tenens contest.

12 Feb 2015

UT Southwestern gets NCI grant to establish Heavy Ion Radiation Therapy Research Center in US

UT Southwestern Medical Center is leading a Texas consortium of researchers to establish the country's first National Center for Heavy Ion Radiation Therapy that could provide clinical care and research using heavy particles for innovative new cancer treatments.

12 Feb 2015

HealthMine survey reveals consumers want more guidance on their health care plan

While the healthcare industry focuses on consumer confusion about benefits, it's the ability to understand and interpret personal health information that may be the larger issue.

12 Feb 2015

Cannabis Science highlights more attendees at the CFA African Healthcare Infrastructure Forum and Brainstorm

Cannabis Science, Inc., a U.S. Company specializing in cannabis formulation-based drug development and related consulting, highlights additional attendees at the CFA African Healthcare Infrastructure Forum and Brainstorm held at the African Union, in Washington DC, on February 6, 2015.

12 Feb 2015

Breckenridge files Paragraph IV ANDA litigation with Sanofi for generic version of Jevtana

Breckenridge Pharmaceutical, Inc. announced today that it has filed an ANDA with a Paragraph IV certification for cabazitaxel solution; IV (infusion) in 60 mg/1.5 mL (40 mg/mL) strength, a generic version of Jevtana® by Sanofi.

12 Feb 2015

Megger raises $5,500 during its 14th annual Megger Distributor Golf Event

Megger, one of the world's leading manufacturers and suppliers of test equipment and measuring instruments for electrical power applications, successfully raised $5,500 during its 14th annual Megger Distributor Golf Event on Saturday, January 24. T

12 Feb 2015

New breakthrough vaccine could treat Triple Negative breast cancer

26.2 with DONNA The National Marathon to Finish Breast Cancer is thrilled to announce a stunning new development that could mean a vaccine for some women with Triple Negative Breast Cancer, an aggressive type of breast cancer that tends to strike young women, African American women, and women of Hispanic descent.

12 Feb 2015

NanoSmart's ANA-conjugated liposomal doxorubicin receives FDA Orphan Drug Designation

NanoSmart Pharmaceuticals, Inc., a private pharmaceutical company developing nanoparticle drug delivery platforms, has received Orphan Drug Designation from the Food and Drug Administration for one of its lead candidates, antinuclear antibody (ANA) conjugated liposomal doxorubicin.

11 Feb 2015

FDA advisory committees to review Amgen's talimogene laherparepvec for metastatic melanoma treatment

Amgen announced today that the Cellular, Tissue and Gene Therapies Advisory Committee and the Oncologic Drugs Advisory Committee of the U.S. Food and Drug Administration will jointly review the Company's Biologics License Application (BLA) for talimogene laherparepvec.

11 Feb 2015

New article assesses 40 years of intensive effort to improve end-of-life care

After four decades of work - first on patients' rights, then on family and caregiving relationships, and most recently on systemic reform -- we now know that it will take additional efforts in all three areas to improve care at the end of life, concludes an article in the New England Journal of Medicine.

11 Feb 2015

AXT establishes preclinical imaging portfolio with MR solutions product lines

To coincide with the start of Lorne Cancer conference, AXT are proud to announce the commencement of their distributorship with MR SOLUTIONS, a world leader in the development of innovative preclinical imaging solutions

From MR Solutions 11 Feb 2015

Movement Disorder Center at UC San Diego designated Center of Excellence in NPF's global network

The Movement Disorder Center at UC San Diego Health System has been designated the 41st Center of Excellence in the National Parkinson Foundation's global network. This competitive designation is the highest recognition offered by NPF to a Parkinson's specialty clinic and represents the consensus of leaders in the field that the multidisciplinary clinic at UC San Diego Health System is among the world's leading centers for Parkinson's research, outreach and care.

11 Feb 2015

First human clinical study of ChromaDex's NIAGEN nicotinamide riboside meets primary endpoint

ChromaDex Corp. announced today that the initial results of the first human clinical study for the company's NIAGEN nicotinamide riboside (NR) has met its primary endpoint.

11 Feb 2015

Oncolytics' REOLYSIN receives FDA Orphan Drug Designation for treatment of ovarian cancer

Oncolytics Biotech Inc., a clinical-stage biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics, today announced that the U.S. Food and Drug Administration has granted Orphan Drug Designation for its lead product candidate, REOLYSIN, for the treatment of ovarian cancer.

11 Feb 2015

Cancer News and Research

Latest Cancer News and Research

Study shows targeted therapeutic after chemotherapy kills transitional cancer cells

Common protein may play strategic role in tumor growth

Opioid withdrawal in Ontario newborns increases 15-fold

Researchers develop novel approach to identify potential antimalarial drugs

Franziska Michor named winner of Creative Promise Prize in Biomedical Science

Cervical treatment procedures do not affect fertility, shows study

Sanford Health wins LocumTenens.com's Best Places to Practice Locum Tenens contest

UT Southwestern gets NCI grant to establish Heavy Ion Radiation Therapy Research Center in US

HealthMine survey reveals consumers want more guidance on their health care plan

Cannabis Science highlights more attendees at the CFA African Healthcare Infrastructure Forum and Brainstorm

Breckenridge files Paragraph IV ANDA litigation with Sanofi for generic version of Jevtana

Megger raises $5,500 during its 14th annual Megger Distributor Golf Event

New breakthrough vaccine could treat Triple Negative breast cancer

NanoSmart's ANA-conjugated liposomal doxorubicin receives FDA Orphan Drug Designation

FDA advisory committees to review Amgen's talimogene laherparepvec for metastatic melanoma treatment

New article assesses 40 years of intensive effort to improve end-of-life care

AXT establishes preclinical imaging portfolio with MR solutions product lines

Movement Disorder Center at UC San Diego designated Center of Excellence in NPF's global network

First human clinical study of ChromaDex's NIAGEN nicotinamide riboside meets primary endpoint

Oncolytics' REOLYSIN receives FDA Orphan Drug Designation for treatment of ovarian cancer

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Cancer News and Research

Latest Cancer News and Research

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in